Evidence map›Paper›PMID 22658432›Full record

Trial reportEpilepsy & behavior : E&B2012

The effect of topiramate plasma concentration on linguistic behavior, verbal recall and working memory.

S E Marino, S V S Pakhomov, S Han, K L Anderson, M Ding, L E Eberly, D W Loring, C Hawkins-Taylor, J O Rarick, I E Leppik and 2 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Epilepsy & behavior : E&B, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Brain's compensatory response to drug-induced cognitive impairment.Journal of clinical and experimental neuropsychology · 2018
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

S E MarinoCenter for Clinical and Cognitive Neuropharmacology, University of Minnesota, Minneapolis, MN 55414, USA. marin007@umn.edu
S V S Pakhomov
S Han
K L Anderson
M Ding
L E Eberly
D W Loring
C Hawkins-Taylor
J O Rarick
I E Leppik
J E Cibula
A K Birnbaum

Funding

Forecasting Topiramate's Effect on Cognitive FunctionK01NS050309 · NINDS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MARINO, SUSAN E · 2005 to 2009
$720k
NIA NIH HHS R01 AG026490NINDS NIH HHS K01 NS050309
6 · The paper itself

Abstract

This is the first study of the effect of topiramate on linguistic behavior and verbal recall using a computational linguistics system for automated language and speech analysis to detect and quantify drug-induced changes in speech recorded during discourse-level tasks. Healthy volunteers were administered a single, 100-mg oral dose of topiramate in two double-blind, randomized, placebo-controlled, crossover studies. Subjects' topiramate plasma levels ranged from 0.23 to 2.81 μg/mL. We found a significant association between topiramate levels and impairment on measures of verbal fluency elicited during a picture description task, correct number of words recalled on a paragraph recall test, and reaction time recorded during a working memory task. Using the tools of clinical pharmacology and computational linguistics, we elucidated the relationship between the determinants of a drug's disposition as reflected in plasma concentrations and their impact on cognitive functioning as reflected in spoken language discourse.

Indexed as

AdolescentAdultCross-Over StudiesDouble-Blind MethodFemaleFructoseHumansMaleMemory, Short-TermMental RecallMiddle AgedNeuropsychological TestsReaction TimeSpeechTopiramateVerbal LearningFructoseTopiramate

Identifiers

PMID22658432
PMCPMC3804073

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.